Abstract 1572: Dystrophin Is a tumor suppressor in human cancers with myogenic programs

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Research

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1538-7445.AM2014-1572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies

  2025cites this paper
• Deficient Astrocyte Homeostatic Support Contributes to Brain Impairment in Duchenne Muscular Dystrophy

  2025cites this paper
• Integrated screens identify AURKB dependency in advanced gastrointestinal stromal tumors.

  2025cites this paper
• Protocol for AI-supported immunofluorescence colocalization analysis in human enteric neurons

  2025cites this paper
• Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?

  2025cites this paper
• Diagnostic value of dystrophin immunostaining for histopathologic diagnosis of uterine smooth muscle tumors.

  2025cites this paper
• Integrated Epigenetic and Transcriptomic Profiling Reveals Dynamic Regulatory Networks Driving Retinoblastoma Pathogenesis

  2025cites this paper
• Machine-learning and scRNA-Seq-based diagnostic and prognostic models illustrating survival and therapy response of lung adenocarcinoma

  2024cites this paper
• Ablation of the dystrophin Dp71f alternative C-terminal variant increases sarcoma tumour cell aggressiveness.

  2024cites this paper
• Molecular basis of proteolytic cleavage regulation by the extracellular matrix receptor dystroglycan

  2024cites this paper
• Genomic and transcriptomic landscape of human gastrointestinal stromal tumors

  2024cites this paper
• Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review

  2024cites this paper
• The spectrum and significance of secondary (co‐occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis

  2023cites this paper
• Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development

  2023cites this paper
• Replication stress in mammalian embryo development, differentiation, and reprogramming.

  2023cites this paper
• Telomere-Associated Gene Signatures Correlate with Prognosis, Tumor Microenvironment, and Chemosensitivity in Breast Cancer

  2023cites this paper
• Ectopic PLAG1 induces muscular dystrophy in the mouse.

  2023cites this paper
• Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557–558 Deletion Mutations

  2023cites this paper
• Hallmarks and novel insights for gastrointestinal stromal tumors: A bibliometric analysis.

  2023cites this paper
• LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD

  2023cites this paper
• Sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) expression in gastrointestinal stromal tumours.

  2023cites this paper
• Analysis of Recurrent DNA Base Pair Mismatches in Eye Cancer Patient Genomes

  2023cites this paper
• Therapeutic approaches for Duchenne muscular dystrophy

  2023cites this paper
• Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential

  2023cites this paper
• Identification of a seven-gene signature and establishment of a prognostic nomogram predicting overall survival of triple-negative breast cancer

  2023cites this paper
• Loss of DMD gene expression results in Duchenne-like molecular abnormalities across diverse tissues

  2022influential citation
• Dystrophin missense mutations alter focal adhesion tension and mechanotransduction

  2022cites this paper
• The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.

  2022cites this paper
• Risk-Related Genes and Associated Signaling Pathways of Gastrointestinal Stromal Tumors

  2022cites this paper
• Full-length dystrophin is expressed across human tissues and DMD downregulation commonly occurring in tumours coincides with Duchenne-like molecular alterations

  2022influential citation
• Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma

  2022cites this paper
• Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma

  2022cites this paper
• Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application.

  2022cites this paper
• Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD

  2022cites this paper
• Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients

  2022influential citation
• Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

  2022cites this paper
• Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST

  2022cites this paper
• Proteins implicated in muscular dystrophy and cancer are functional constituents of the centrosome

  2022influential citation
• Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy

  2021cites this paper
• Update on Molecular Genetics of Gastrointestinal Stromal Tumors

  2021cites this paper
• Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy

  2021cites this paper
• Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors

  2021cites this paper
• Integrative RNA-Seq and H3 Trimethylation ChIP-Seq Analysis of Human Lung Cancer Cells Isolated by Laser-Microdissection

  2021cites this paper
• Systematic analysis of genetic variation of Duchenne muscular dystrophy and implication for cancer

  2021cites this paper
• E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer

  2021cites this paper
• Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling

  2021cites this paper
• Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival

  2021cites this paper
• The genomics and epigenetics of olfactory neuroblastoma: A systematic review

  2021cites this paper
• Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival

  2021cites this paper
• Gastrointestinal stromal tumours

  2021cites this paper
• Rhabdomyosarcoma in a Patient With Duchenne Muscular Dystrophy: A Possible Association

  2021influential citation
• A high-risk alveolar rhabdomyosarcoma case with Duchenne muscular dystrophy.

  2021cites this paper
• Risk stratification of gastrointestinal stromal tumors by Nanostring gene expression profiling

  2021cites this paper
• RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing

  2021cites this paper
• E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor

  2021cites this paper
• Dystrophin Dp71 Subisoforms Localize to the Mitochondria of Human Cells

  2021cites this paper
• Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts

  2021cites this paper
• Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy

  2021cites this paper
• Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion

  2021cites this paper
• Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy

  2020cites this paper
• The Duchenne muscular dystrophy gene and cancer

  2020cites this paper
• NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

  2020cites this paper
• Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas

  2020cites this paper
• Tetraploidization of Immortalized Myoblasts Induced by Cell Fusion Drives Myogenic Sarcoma Development with DMD Deletion

  2020influential citation
• Investigation of Unknown Causes of Uveal Melanoma Uncovers Seven Recurrent Genetic Mutations

  2020cites this paper
• Genomic and Transcriptomic Analyses of Osteogenic Tumours of Bone

  2020cites this paper
• Gastrointestinal Stromal Tumor: Challenges and Opportunities for a New Decade

  2020cites this paper
• Pilocytic Astrocytoma Tissue from a 25-year-old Patient with Duchenne Muscular Dystrophy Expresses the DMD Transcript but Not Protein

  2020cites this paper
• Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis.

  2020cites this paper
• Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma

  2019cites this paper
• Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer

  2019cites this paper
• Genetic profiling of a chondroblastoma‐like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1‐FGFR1 gene fusion

  2019cites this paper
• Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

  2019cites this paper
• Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas

  2019influential citation
• Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2

  2019cites this paper
• Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor

  2019cites this paper
• Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)

  2019cites this paper
• Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome

  2019cites this paper
• X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma

  2019cites this paper
• Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors

  2019cites this paper
• Schwann cell-specific Dp116 is expressed in glioblastoma cells, revealing two novel DMD gene splicing patterns

  2019cites this paper
• Translational investigations of novel and current antitumoral therapies in gastrointestinal stromal tumors

  2019cites this paper
• Muscle Stem Cells Give Rise to Rhabdomyosarcomas in a Severe Mouse Model of Duchenne Muscular Dystrophy.

  2019cites this paper
• Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress

  2019cites this paper
• The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility

  2019cites this paper
• Leiomyosarcomas: whole genome sequencing for a whole biology characterization.

  2019cites this paper
• ABC of multifaceted dystrophin glycoprotein complex (DGC)

  2018cites this paper
• Molecular characterization and pathogenesis of gastrointestinal stromal tumor.

  2018cites this paper
• Canine sarcomas as a surrogate for the human disease

  2018cites this paper
• Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece

  2018cites this paper
• Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene

  2018cites this paper
• Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

  2018cites this paper
• Recent advances in the diagnosis of soft tissue tumours.

  2018cites this paper
• RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.

  2018cites this paper
• DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

  2018cites this paper
• Sex-specific gene and pathway modeling of inherited glioma risk

  2018cites this paper
• Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.

  2018cites this paper
• Gastrointestinale Stromatumoren

  2018cites this paper
• Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function

  2018cites this paper
• Oncogenic Amplification of Zygotic Dux Factors in Regenerating p53-Deficient Muscle Stem Cells Defines a Molecular Cancer Subtype.

  2018cites this paper